Filter By Industry
Filter By Tag

Newsroom

Biopharma PEG Scientific Inc. Press releases

11 - 20 of 41 Press Releases

Jan 28, 2023
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy. So far, there are only 15 drugs on the market in the world.

Nov 28, 2022
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network.

Oct 25, 2022
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine.

Sep 26, 2022
Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine agent in clinical studies, many advances have been made in the field of mRNA therapeutic technology after nearly 30 years of development.

Aug 24, 2022
In recent years, the scope and application scenarios of drug conjugates, including multiple concepts such as combination medication and precise drug delivery, have continued to expand, and a variety of emerging conjugation technology concepts have...

Jul 26, 2022
PROTACs (Proteolysis-targeting Chimeras), which was first proposed by Crews et al in 2001, can reduce protein levels rather than inhibit protein functions by taking advantage of the natural protein cleaning system in the body.

Jun 28, 2022
In recent years, targeted protein degraders have entered the mainstream of drug development at a very rapid rate.

May 26, 2022
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine.

Apr 20, 2022
Nmerous applications of PEGs have been reported in the scientific literature over the years.

Mar 29, 2022
Just one dose of a new nanoparticle-based COVID-19 vaccine is enough to generate an immune response in animals, and the vaccines currently in clinical use are on track.


Page: Prev 1 2 3 4 5 Next
Biopharma PEG Scientific Inc. RSS Feed